Medical device maker Stryker said it has reached a deal to acquire Inari Medical for $80 per share in cash, representing an ...

Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion late Monday. Inari stock catapulted on the news ...

Risk for venous thromboembolism during pregnancy increased significantly from 2009 to 2019, with an average annual percent ...

Fintel reports that on January 7, 2025, William Blair downgraded their outlook for Inari Medical (NasdaqGS:NARI) from ...

At its height, NAIAS in Detroit was truly an international show, where anyone involved in the auto industry was expected to ...

Medical-device maker Stryker has agreed to acquire Inari Medical, which makes devices that treat patients with venous ...

After professing a hearty appetite for tuck-in M&A last year and signing a string of smaller deals, Stryker is now opening ...

Canaccord Genuity Group reiterated their hold rating on shares of Inari Medical (NASDAQ:NARI – Free Report) in a research ...

J&J has reported positive topline outcomes from the MARIPOSA trial of RYBREVANT and LAZCLUZE combo for NSCLC treatment.

Portage: Stryker, a medical technologies company, has announced a definitive agreement to acquire all of the issued and ...

Wells Fargo & Company reaffirmed their equal weight rating on shares of Inari Medical (NASDAQ:NARI – Free Report) in a report issued on Tuesday,Benzinga reports. The firm currently has a $80.00 price ...

Inari Medical (NARI – Research Report) received a Hold rating and price target from BTIG analyst Marie Thibault today. The company’s shares ...